Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: Lack of protection and a proarrhythmic effect

Circulation: Arrhythmia and Electrophysiology

Volumn 5, Issue 3, 2012, Pages 553-560

  Billman, George E ^a   Carnes, Cynthia A ^a   Adamson, Philip B ^b   Vanoli, Emilio ^c   Schwartz, Peter J ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b Oklahoma Heart Hospital   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Fish oil; Myocardial infarction; Myocardial ischemia; Omega 3 polyunsaturated fatty acids; Ventricular fibrillation

Indexed keywords

CORN OIL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DISEASE PREDISPOSITION; ERYTHROCYTE; EXERCISE TEST; FAT INTAKE; HEART INFARCTION; HEART PROARRHYTHMIA; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DEATH, SUDDEN, CARDIAC; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FATTY ACIDS, OMEGA-3; FEMALE; MALE; PHYSICAL CONDITIONING, ANIMAL; PROGNOSIS; TREATMENT FAILURE; VENTRICULAR FIBRILLATION;

EID: 84862883886     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.111.966739     Document Type: Article

References (50)

1. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978;2:117-119. (Pubitemid 8373454)
2. Kromhout D, Bosschieter EB, de Lezenne CC. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-1209. (Pubitemid 15009153)
3. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fehily AM, Rogers S, Sweetnam PM, Deadman NM. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART). Lancet. 1989;2:757-761. (Pubitemid 19234807)
4. Nilsen DWT, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie. Effects of a high-dose concentrate on n-3 fatty acids or corn oil introduced early after acute myocardial infarction on serum triacylglyerol and HDL cholesterol. Am J Clin Nutr. 2001;74:50-56. (Pubitemid 32577089)
5. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppi G, Mininni N, Nicolisi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897-1903. (Pubitemid 34437615)
6. Burr ML, Ashfield-Watt PA, Dunstan FD, Fehily AM, Breay P, Ashton T, Zotos PC, Haboubi NAA, Elwood PC. Lack of benefit of dietary advice to men with angina: results of controlled trial. Eur J Clin Nutr. 2003;57:193-200. (Pubitemid 36240469)
7. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, Kitabatake A, Nakaya N, Sakata T, Shimada K, Shirato K; Japan EPA Lipid Intervention Study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolemic (JELIS): a randomized open-label, blinded endpoint analysis. Lancet. 2007;369:1090-1098. (Pubitemid 46483662)
8. GISSI-HF investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet. 2008;372:1223-1230.
9. Rauch B, Schiele R, Schneider S, Diller F, Victor N, Gohlke H, Gottwik M, Steinbeck G, Del Castillo U, Sack R, Worth H, Katus H, Spitzer W, Sabin G, Senges J; for the OMEGA Study Group. OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122:2152-2159.
10. Kromhout D, Giltay EJ, Geleijnse JM. for the Alpha Omega Trial Group. n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363:2015-2026.
11. Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D. Prevention of fatal arrhythmias in high- risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112: 2762-2768. (Pubitemid 41641669)
12. Raitt MH, Connor WE, Morris C, Kron J, Halpren B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, Conner SL, Gerhard G, Kraemer DF, Oseran D, Marchant C, Calhoun D, Shnider R, McAnulty J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293:2884-2891. (Pubitemid 41029142)
13. Brouwer IA, Zock PL, Camm AJ, Boecker D, Hauer RN, Wever EF Dullemeijer C, Ronden JE, Katan MB, Lubinski A, Buschler H, Schouten EG; SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the study on omega-3 fatty acids and ventricular arrhythmias (SOFA). JAMA. 2006;295:2613-2619. (Pubitemid 43882336)
14. De Caterina R. n-3 Fatty acids in cardiovascular disease. N Engl J Med. 2011;364:2439-2450.
15. Kris-Etherton PM, Harris WS, Appel LJ; for the AHA Nutrition Committee. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23:151-152. (Pubitemid 36231919)
16. Billman GE, Hallaq H, Leaf A. Prevention of ischemia-induced ventricular fibrillation by omega-3 fatty acids. Proc Natl Acad Sci U|S|A. 1994;91:4427-4430. (Pubitemid 24143446)
17. Billman GE, Kang JX, Leaf A. Prevention of sudden death by dietary pure n-3 polyunsaturated fatty acids in dogs. Circulation. 1999;99: 2542-2457.
18. Anders BP, Weber AR, Rampersad PP, Gilchrist JSC, Pierce GN, Lukas A. Dietary flax seed protects against ventricular fibrillation induced by ischemia-reperfusion in normal and hypercholestrolemic rabbits. J Nutr. 2004;134:3250-3256. (Pubitemid 39602994)
19. Dhein S, Michaelis B, Mohr FW. Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids. Naunyn- Schmiedebergs Arch Pharmacol. 2005;371:202-211. (Pubitemid 40768412)
20. Den Ruijter HM, Bercki G, Opthof T, Verkerk AO, Zock PL, Coronel R. Pro- and anti-arrhythmic properties of diet rich in fish oil. Cardiovasc Res. 2007;73:316-325. (Pubitemid 44940880)
21. Coronel R, Wilms-Schopman FJG, Den Ruijter HM, Beltermean CN, Schumacher CA, Opthof T, Hovenier R, Lemmens AG, Terpstra AHM, Katan MB, Zock P. Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts. Cardiovasc Res. 2007;73:386-394. (Pubitemid 44963519)
22. Schwartz PJ, Billman GE, Stone HL. Autonomic mechanisms in ventricular fibrillation due to acute myocardial ischemia during exercise in dogs with healed myocardial infarction: an experimental model for sudden cardiac death. Circulation. 1984;69:790-800. (Pubitemid 14125661)
23. Billman GE. A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development. Pharmacol Therap. 2006;111:808-835. (Pubitemid 44160523)
24. Bligh EG, Dyer WJ. A rapid method for total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
25. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res. 1964;5:600-608.
26. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res. 1988;22: 447-455.
27. Schwartz PJ. Do animal models have clinical value? Am J Cardiol. 1998;81:14D-20D. (Pubitemid 28155906)
28. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, Durrington PN, Ness AR, Capps NE. G Davey-Smith, Riemersma RA, Ebrahim SB. Omega-3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev. 2004;4:CD003177.
29. Filion KB, El Khoury F, Bielinski M, Schiller I, Dendukuri N, Brophy JM. Omega-3 fatty acids in high-risk cardiovascular patients: a metaanalysis of randomized controlled trials. BMC Cardiovasc Discord. 2010;10:24.
30. Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, Xu Y, Guo JH. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: meta-analysis of randomized controlled trials. Ann Med. 2009;41:301-310.
31. Leon H, Shibata MC, Sivakumaran, Dorgan M, Chatterley T, Tsuyuki RT. Effect of fish oil on arrhythmias and mortality: systematic review. Br Med J. 2009;338:a2931.
32. Wilhelm M, Tobis R, Asskali F, Kraehner R, Kuly S, Klinghammer L, Boehles H, Daniel WG. Red blood cell omega-3 fatty acids and the risk 560 Circ Arrhythm Electrophysiol June 2012 of ventricular arrhythmias in patients with heart failure. Am Heart J. 2008;155:971-977.
33. Brouwer IA, Riatt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, Katan MB, Connor WE, Camm JA, Schouten EG, McAnulty J. Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators. Eur Heart J. 2009;30:820-826.
34. Jenkins DJ, Josse AR, Beyene J, Dorian P, Burr ML, LaBelle R, Kendall CW, Cunnane SC. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. Can Med Assoc J. 2008;178:157-164.
35. McLennan PL, Abeywardena MY, Charnock JS. Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion. Am Heart J. 1988;116:709-717.
36. McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey. Am Heart J. 1992;123:1555-1561.
37. Matthan NR, Jordan H, Chung M, Lichtenstein AH, Lathrop DA, Lau J. A systematic review and meta-analysis of the impact of ω-3 fatty acids on selected arrhythmia outcomes in animal models. Metabol Clin Exp. 2005;54:1557-1565. (Pubitemid 41728145)
38. Abildstrom SZ, Kobler L, Torp-Pedersen C. Epidemiology of arrhythmic and sudden death in the chronic phase of ischemic heart disease. Cardiac Electrophysiol Rev. 1999;3:177-179.
39. Schuster EH, Bulkley BH. Ischemia at a distant site after myocardial infarction: a cause of early postinfarction angina. Circulation. 1980;62:509-515. (Pubitemid 10059062)
40. Billman GE. Cardiac autonomic neural "remodeling" and susceptibility to sudden cardiac death: effect of endurance exercise training. Am J Physiol Heart Circ Physiol. 2009;297:H1171-H1193.
41. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478-484. (Pubitemid 28070094)
42. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden death. Circulation. 1982;66:874-880. (Pubitemid 12015075)
43. Schwartz PJ, Vanoli E, Stramba-Badiale M, DeFerrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death, new insight from the analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation. 1988;78:969-979.
44. Von Schacky C. A review of omega-3 ethyl esters for the cardiovascular prevention and treatment of increased blood triglyceride levels. Vasc Health Risk Manag. 2006;2:251-262.
45. Kowey PR, Reiffel JA, Ellenbogen KA, Naccarelli GV, Pratt CM. Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA. 2010;304:E1-E10.
46. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J, Bouberg V, Arbogast P, Smith H, Kushi LH, Cobb LA, Copass MK, Psaty B, Lemaitre R, Retzlaff B, Childs M, Knopp RH. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363-1367.
47. Albert CM, Campos H, Stampfer MJ, Ridker PM, Mason JE, Willet WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-1118. (Pubitemid 34984601)
48. Sridhar A, Nishijima Y, Terentyev D, Terentyeva R, Uelman R, Kukielka M, Bonilla IM, Robertson GA, Gyorke S, Billman GE, Carnes CA. Repolarization abnormalities and afterdepolarizations in a canine model of sudden cardiac death. Am J Physiol Reg Integ Physiol. 2008;295: R1463-R1472.
49. Swann MH, Nakagawa H, Vanoli E, Lazzara R, Schwartz PJ, Adamson PB. Heterogeneous regional endocardial repolarization is associated with increased risk fro ischemia-dependent ventricular fibrillation after myocardial infarction. J Cardiovasc Elctrophysiol. 2003;14:873-879. (Pubitemid 36994107)
50. Belevych A, Terentyev D, Sridhar A, Nishijima Y, Wilson LD, Cardounel AJ, Laurita K, Carnes CA, Billman GE, Gyorke S. Redox-modification of ryanodine receptors underlies sarcoplasmic reticulum luminal calcium dependent cardiac alternans in a canine model of sudden cardiac death. Cardiovasc Res. 2009;84:387-395.